RT Journal Article
SR Electronic
T1 Impact of exercise on regadenoson side effects during myocardial perfusion stress imaging
JF Journal of Nuclear Medicine
JO J Nucl Med
FD Society of Nuclear Medicine
SP 2003
OP 2003
VO 50
IS supplement 2
A1 Khandekar, Shashi
A1 Kwon, Deborah
A1 Brunken, Richard
A1 Cerqueira, Manuel
A1 Jaber, Wael
A1 Young, Ron
A1 Menon, Venu
YR 2009
UL http://jnm.snmjournals.org/content/50/supplement_2/2003.abstract
AB 2003 Objectives A new selective, A2A Adenosine receptor agonist is now available for pharmacologic stress myocardial perfusion stress imaging. We hypothesized that the use of treadmill exercise might impact the side effects considered with this agent. Methods 643 consecutive in patients and out patients underwent myocardial perfusion stress imaging of which 360 were female, mean age 66.8 ± 12.4, mean BMI 30.8 ± 7.5 and 126 had history of COPD/asthma. Results There were no major side effects or malignant arrhythmias reported during stress test including no deaths. Major symptoms and parameters are described below in Table 1. Conclusions Regadenoson appears to be safe and well-tolerated. Shortness of breath and palpitations seem to be less frequent when patients are able to exercise. A significant fall in blood pressure seems to be more common in patients who exercise.